{"disease":{"id":"hepatecellular-carcinoma","name":"hepatecellular carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07319299","title":"STOP HCC-GAAD-APAC-Thailand","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2100,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT07277192","title":"HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival","phase":"","overall_status":"COMPLETED","enrollment_count":562,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07062380","title":"AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)","phase":"","overall_status":"RECRUITING","enrollment_count":353,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07327788","title":"QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07482670","title":"Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07436988","title":"Affordable Made-in-India Microspheres for Liver Cancer Therapy","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}